Related Experiment Video
Updated: Sep 4, 2025
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
30.6K
Developing Strategic Recommendations for Implementing Smart Pumps in Advanced Healthcare Systems to Improve
Adam Sutherland1, Matthew D Jones2, Moninne Howlett3,4
1Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester, M13 9PL, UK. Adam.sutherland@manchester.ac.uk.
Drug Safety
|July 15, 2022
Summary
Implementing smart infusion pumps effectively requires a strategic, human-centered approach. Recommendations focus on standardizing concentrations, developing user-friendly drug libraries, and involving stakeholders to improve medication safety.
Area of Science:
- Health Systems Science
- Medication Safety Technology
- Clinical Informatics
Background:
- Medication administration errors pose a significant risk in healthcare.
- Smart infusion pumps are intended to reduce these errors but face implementation challenges.
- Variations in medication preparation and use complicate technology integration.
Purpose of the Study:
- To discuss the current state of medication administration technology.
- To propose strategic recommendations for effective smart pump implementation.
- To enhance medication safety through technology adoption.
Main Methods:
- A virtual symposium of 36 medication safety experts.
- Discussion of the 'state of the art' in smart pump technology.
- Development of strategic recommendations for implementation.
Main Results:
- Standardize infusion concentrations for ready-to-administer formulations.
- Develop drug libraries using human-centered design and standard concentrations.
- Establish standardized metrics for interpreting infusion device data.
- Involve all stakeholders in drug library and metric development.
- Collaborate with manufacturers on device design.
Conclusions:
- A strategic, human-centered approach is crucial for successful smart pump implementation.
- Standardization and stakeholder involvement are key to improving medication safety.
- Further implementation studies are needed to quantify safety, efficiency, and cost-effectiveness benefits.
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K
01:29Venous Thrombosis III: Interprofessional Care
20
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
20
01:25Routes of Drug Administration: Parenteral
2.1K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.1K
01:22Acute Kidney Injury VI: Nursing Management
54
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
54
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
311
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
311
01:22Heart Failure VI: Adjunct Therapies
25
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25